Cargando…
Leukocyte immunoglobulin‐like receptor A3 is increased in IBD patients and functions as an anti‐inflammatory modulator
Growing evidence shows that a homozygous 6·7‐kb deletion of the novel anti‐inflammatory molecule leukocyte immunoglobulin‐like receptor A3 (LILRA3) is associated with many autoimmune disorders. However, its effects on pathogenesis of inflammatory bowel disease (IBD) have yet not been clarified. LILR...
Autores principales: | Lan, X., Liu, F., Ma, J., Chang, Y., Xiang, L., Shen, X., Zhou, F., Zhao, Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806419/ https://www.ncbi.nlm.nih.gov/pubmed/33006756 http://dx.doi.org/10.1111/cei.13529 |
Ejemplares similares
-
Leukocyte Immunoglobulin-Like Receptors (LILRs) on Human Neutrophils: Modulators of Infection and Immunity
por: Lewis Marffy, Alexander L., et al.
Publicado: (2020) -
Human leukocyte immunoglobulin-like receptors in health and disease
por: Redondo-García, Silvia, et al.
Publicado: (2023) -
Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019) -
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
por: Deng, Mi, et al.
Publicado: (2021) -
Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)